How long is each Foundayo dose step held?

At least thirty days before any increase, at every rung of the ladder. Holding longer is fine and often sensible if the gastrointestinal effects have not settled — the slow pace is the thing keeping them manageable, so hurrying tends to backfire.

What if I forget a Foundayo tablet?

If you notice the same day, take it and carry on normally. If tomorrow has already arrived, let the missed one go and take that day's tablet at the usual time. Two tablets in a day is never the answer. The weekly injectables use completely different rules, so do not transfer a habit from one to the other.

Does Foundayo need an empty stomach?

No, and that is its main practical advantage. Oral semaglutide is a peptide that struggles to survive digestion, which is why its label demands an empty stomach, a measured sip of water and a wait. Orforglipron, built as a small molecule instead, needs none of that — at whatever hour suits, eaten or not.

Does Foundayo interact with other medications?

More than the injectable GLP-1s do, because it is cleared through CYP3A4 as small molecules are. Strong inhibitors of that enzyme pull your maximum down to 9 mg, strong inducers should be avoided, simvastatin is capped at 20 mg, and anyone using an oral contraceptive is directed onto a non-oral method or told to add a barrier method. Give your prescriber the full list.

Foundayo Dose Steps 2026: the Oral GLP-1 Ladder

Foundayo is orforglipron, from Eli Lilly, approved on 1 April 2026 for weight management. It is the first GLP-1 tablet licensed for that purpose, and unlike oral semaglutide it is not a peptide — which is precisely why it comes with no fasting window and no elaborate instructions about water.

One tablet daily. Swallow it whole. Never more than one in a day.

The ladder

Dose	Hold at least	What it is
0.8 mg	30 days	A run-up rather than a treatment dose. Its purpose is your stomach, not your weight.
2.5 mg	30 days	The first step that is doing something. Stay longer if the nausea has not settled.
5.5 mg	30 days	Middle of the ladder.
9 mg	30 days	A perfectly reasonable place to stop if the rungs above disagree with you.
14.5 mg	30 days	Second from top. Staying here is allowed if it works and you tolerate it.
17.2 mg	—	The maximum, and the dose that produced the headline trial result.

Each step is held a minimum of thirty days, and whether you climb past the middle depends on how you are responding and what you can tolerate. 17.2 mg is a ceiling, not a destination.

Taking it

Food is irrelevant. No empty stomach, no measured sip of water, no waiting before breakfast. This is the clearest practical difference from oral semaglutide, and it comes from chemistry rather than convenience — a non-peptide does not need shielding from your digestion.
Same time each day, whichever time actually fits your life.
Whole. Not split, crushed or chewed.
One a day, maximum, no matter what happened yesterday.
No fridge, no needles.

Interactions — the part that is easy to skip

⛔ This is where a tablet is more complicated than an injection. Orforglipron is processed by CYP3A4, so other medicines change its levels and it changes theirs. Injectable GLP-1s are peptides and largely avoid this territory altogether.

Strong CYP3A4 inhibitors: your maximum drops to 9 mg a day. If the drug also blocks OATP1B, do not combine them at all.
Strong CYP3A4 inducers: avoid. With moderate ones, expect Foundayo to work less well and the dose to need review.
Simvastatin: held to 20 mg daily alongside it.
Oral contraceptives: the label moves users onto something that is not swallowed, or asks for a barrier method alongside. Read that alongside the fact that the drug can harm a developing pregnancy and should stop as soon as one is known about.
Other tablets generally: gastric emptying slows, which can change how they are absorbed.

A missed tablet

Simpler than the weekly injectables, because the schedule is daily.

Same day, remembered late? Take it, then carry on as usual.
Already the next day? Leave it and take that day's tablet as usual.
Two in one day: never. It buys nothing and costs you a day of nausea.

The weekly injections work on entirely different arithmetic — windows of four or five days — so do not carry a habit from one to the other.

Reasons to pause and call

Severe abdominal pain reaching through to the back. Pancreatitis. Stop and get assessed.
Pain under the right ribs, fever, or yellowing. Gallbladder disease is a known class effect.
Dehydration after prolonged vomiting or diarrhea. Kidney injury has followed this across the class. Hold the next dose, rehydrate, ring someone.
A new neck lump, hoarseness, difficulty swallowing. The boxed warning covers thyroid C-cell tumors. Anyone with medullary thyroid carcinoma in their history or their family's, or with MEN 2, cannot take this drug at all.
Symptomatic low blood sugar, most likely alongside insulin or a sulfonylurea, which may need reducing.
Rash, hives, swelling of the face or throat. Emergency care.

The commonest complaints are gastrointestinal, and roughly one person in twenty stopped the drug in trials because of them.

Outside this page's scope

How well it works. The short answer is 11.1% at the top dose over 72 weeks, which is below both injectable rivals. The longer answer, with the cross-trial caveats that go with it, is on our full write-up.
Diabetes. This license covers weight management. Anything else is a separate question.
Pregnancy, beyond the fact that this drug and pregnancy do not go together.

Where to go next

Our full Foundayo write-up — the trial numbers, the boxed-warning oddity, and what four sellers in the register charge for it.
The Foundayo drug page — label, indications, current pricing.
The Medicare GLP-1 Bridge — Foundayo is one of the covered drugs, at a $50 monthly copay for those eligible.
Brand names against molecules — which pill is which, and why it decides your price.